scholarly journals Novel implantation of vagus nerve stimulator AspireSR pulse generator: Technical note

2017 ◽  
Vol 10 ◽  
pp. 20-23 ◽  
Author(s):  
J. Will Robbins ◽  
Jordan Lacy ◽  
Mark Puccioni
Neurosurgery ◽  
2000 ◽  
Vol 47 (4) ◽  
pp. 985-987 ◽  
Author(s):  
Michael E. Carey ◽  
Scott Kutz

Abstract OBJECTIVE To notify neurosurgeons about a modified bayonet forceps that aids application of the vagus nerve stimulating electrode. METHODS The manufacturer (Codman & Shurtleff, Inc., Raynham, MA) extended the tips of an upward-angled Malis bayonet forceps from 2 mm to 6 mm. RESULTS The modified bayonet tips, when placed under the vagus nerve, extend well beyond the edge of the usual vagus nerve to easily accept the electrode lead. CONCLUSION The modified bayonet forceps and depicted wrapping sequence shorten electrode wrapping time.


2020 ◽  
Vol 99 (7) ◽  

Introduction: Vagus nerve stimulation is a palliative treatment for patients with refractory epilepsy to reduce the frequency and intensity of seizures. A bipolar helical electrode is placed around the left vagus nerve at the cervical level and is connected to the pulse generator placed in a subcutaneous pocket, most commonly in the subclavian region. Methods: Between March 1998 and October 2019, we performed 196 procedures related to the vagal nerve stimulation at the Neurosurgery Department in Motol University Hospital. Of these, 126 patients were vagal nerve stimulator implantation surgeries for intractable epilepsy. The cases included 69 female and 57 male patients with mean age at the time of the implantation surgery 22±12.4 years (range 2.1−58.4 years). Results: Nine patients (7.1%) were afflicted by complications related to implantation. Surgical complications included postoperative infection in 1.6%, VNS-associated arrhythmias in 1.6%, jugular vein bleeding in 0.8% and vocal cord paresis in 2.4%. One patient with vocal cord palsy also suffered from severe dysphagia. One patient (0.8%) did not tolerate extra stimulation with magnet due to a prolonged spasm in his throat. The extra added benefit of vagus stimulation in one patient was a significant reduction of previously regular severe headaches. Conclusion: Vagus nerve stimulation is an appropriate treatment for patients with drug-resistant epilepsy who are not candidates for focal resective surgery. Implantation of the vagus nerve stimulator is a relatively safe operative procedure.


2021 ◽  
Vol 71 ◽  
pp. 110193
Author(s):  
Arthur Chyan ◽  
Sangeeta Kumaraswami ◽  
Suryanarayana Pothula

2016 ◽  
Vol 30 ◽  
pp. 83-87 ◽  
Author(s):  
Sandi Lam ◽  
Yimo Lin ◽  
Daniel J. Curry ◽  
Gaddum D. Reddy ◽  
Peter C. Warnke

2009 ◽  
Vol 41 (5) ◽  
pp. 383-387 ◽  
Author(s):  
Naoaki Tanaka ◽  
Elizabeth A. Thiele ◽  
Joseph R. Madsen ◽  
Blaise F. Bourgeois ◽  
Steven M. Stufflebeam

2016 ◽  
Vol 11 (2) ◽  
pp. 151 ◽  
Author(s):  
Hinaesh Upadhyay ◽  
Sushanth Bhat ◽  
Divya Gupta ◽  
Martha Mulvey ◽  
Sue Ming

2012 ◽  
Vol 10 (3) ◽  
pp. 226-229 ◽  
Author(s):  
Will P. Rodgers ◽  
Andrew J. Durnford ◽  
Fenella J. Kirkham ◽  
Andrea Whitney ◽  
Mark A. Mullee ◽  
...  

Object Interrater reliability as measured by the kappa (κ) statistic is a widely used and valuable tool to measure the robustness of a scoring system. Seizure frequency reduction is a central outcome measure following vagus nerve stimulation (VNS). A specific VNS scoring system has been proposed by McHugh, but its interrater reliability has not been tested. The authors assessed its interrater reliability and compared it with that of the Engel and International League Against Epilepsy (ILAE) systems. Methods Using the Engel, ILAE, and McHugh scoring systems, 3 observers independently rated the medical records of children who had undergone vagus nerve stimulator implantation between January 2001 and April 2011 at the Southampton University Hospital. The interrater agreements were then calculated using the κ statistic. Results Interrater reliability for the McHugh scale (κ0.693) was very good and was superior to those of the Engel (κ0.464) and ILAE (κ0.491) systems for assessing outcome in patients undergoing VNS. Conclusions The authors recommend considering the McHugh scoring system when assessing outcomes following VNS.


Sign in / Sign up

Export Citation Format

Share Document